Professor Carmel Hawley
Professor

Carmel Hawley

Email: 
Phone: 
+61 7 3176 2625

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

715 works between 1965 and 2025
All (715) Journal Article (484) Book Chapter (6) Conference Publication (223) Other Outputs (2)

541 - 560 of 715 works

2008

Conference Publication

Chronic kidney disease following orthotopic liver transplantion

Frazier, J., Lipka, G., Johnson, D., Hawley, C., Campbell, S., Mudge, D., Van Eps, C., Isbel, N. and Macdonald, G. (2008). Chronic kidney disease following orthotopic liver transplantion. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6–10 September 2008. Richmond, VIC, Australia: Wiley-Blackwell.

Chronic kidney disease following orthotopic liver transplantion

2008

Conference Publication

Previous treatment modality of patients entering a contemporary home haemodialysis program: a minority transfer from peritoneal dialysis

Miles, R., Van Eps, C., Jeffries, J., Johnson, D., Campbell, S., Isbel, N., Mudge, D., Burke, J. and Hawley, C. (2008). Previous treatment modality of patients entering a contemporary home haemodialysis program: a minority transfer from peritoneal dialysis. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Sydney, NSW Australia, 6–10 September 2008. Richmond, VIC Australia: John Wiley and Sons.

Previous treatment modality of patients entering a contemporary home haemodialysis program: a minority transfer from peritoneal dialysis

2008

Conference Publication

Prevalence and Risk Factors for Vitamin D Deficiency in Patients with Chronic Kidney Disease in a Subtropical Climate

Siva, B., Duncan, E., Hawley, C. and Isbel, N. (2008). Prevalence and Risk Factors for Vitamin D Deficiency in Patients with Chronic Kidney Disease in a Subtropical Climate. HOBOKEN: WILEY-BLACKWELL.

Prevalence and Risk Factors for Vitamin D Deficiency in Patients with Chronic Kidney Disease in a Subtropical Climate

2008

Journal Article

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial

Johnson, David Wayne, Hawley, Carmel Mary, Rosser, Brenda, Beller, Elaine, Thompson, Charles, Fassett, Robert G., Ferrari, Paolo, MacDonald, Stephen, Pedagogos, Eugenie and Cass, Alan (2008). Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial. BMC Nephrology, 9 (1) 8, 8-1-8-7. doi: 10.1186/1471-2369-9-8

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial

2008

Journal Article

Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation

Nicol, David L., Preston, John M., Wall, Daryl R., Griffin, Anthony D., Campbell, Scott B., Isbel, Nicole M., Hawley, Carmel M. and Johnson, David W. (2008). Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU International, 102 (2), 188-193. doi: 10.1111/j.1464-410X.2008.07562.x

Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation

2008

Conference Publication

Complications of home hemodialysis

Hawley, Carmel M., Jeffries, Janine, Nearhos, Jane and Van Eps, Carolyn (2008). Complications of home hemodialysis. Annual Dialysis Conference 2008, Orlando Fl, Mar 01, 2008. OXFORD: BLACKWELL PUBLISHING. doi: 10.1111/j.1542-4758.2008.00291.x

Complications of home hemodialysis

2008

Journal Article

Is it time to embrace haemodiafiltration for centre-based haemodialysis?

Petrie, J, Ng, T and Hawley, Carmel M. (2008). Is it time to embrace haemodiafiltration for centre-based haemodialysis?. Nephrology, 13 (4), 269-277. doi: 10.1111/j.1440-1797.2008.00964.x

Is it time to embrace haemodiafiltration for centre-based haemodialysis?

2008

Journal Article

Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen

Tey, Siok-Keen, Marlton, Paula V., Hawley, Carmel M., Norris, Debra and Gill, Devinder S. (2008). Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen. American Journal of Hematology, 83 (4), 330-333. doi: 10.1002/ajh.21062

Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen

2008

Journal Article

Automated and continuous ambulatory peritoneal dialysis have similar outcomes

Badve, S., Hawley, C. M., McDonald, S., Mudge, D., Rosman, J., Brown, F. and Johnson, D. W. (2008). Automated and continuous ambulatory peritoneal dialysis have similar outcomes. Kidney International, 73 (4), 480-488. doi: 10.1038/sj.ki.5002705

Automated and continuous ambulatory peritoneal dialysis have similar outcomes

2008

Conference Publication

Off-label use of rituximab in a tertiary referral renal unit

Miles, R., Butterly, S., Pillans, P., Sturtevant, J., Johnson, D., Campbell, S., Hawley, C., Mudge, D. and Van Eps, C. (2008). Off-label use of rituximab in a tertiary referral renal unit. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, NSW Australia, 6-10 September 2008. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Off-label use of rituximab in a tertiary referral renal unit

2008

Journal Article

Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series

Kaisar, M. O., Kirwan, R. M., Strutton, G. M., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2008). Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series. Transplant Infectious Disease, 10 (3), 209-213. doi: 10.1111/j.1399-3062.2007.00273.x

Cutaneous manifestations of cytomegalovirus disease in renal transplant recipients: a case series

2008

Journal Article

Change in live donor characteristics over the last 25 years: A single centre experience

Kaisar, Mohd O., Nicol, David L., Hawley, Carmel M., Mudge, David W., Johnson, David W., Preston, John M., Wall, Daryl R., Griffin, Anthony D., Campbell, Scott B. and Isbel, Nicole M. (2008). Change in live donor characteristics over the last 25 years: A single centre experience. Nephrology, 13 (7), 646-650. doi: 10.1111/j.1440-1797.2008.01039.x

Change in live donor characteristics over the last 25 years: A single centre experience

2008

Conference Publication

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David, Prins, John and Isbel, Nicole (2008). Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study. 8th American Transplant Congress, Toronto, Canada, 31 May - 4 June 2008 . Hoboken, NJ, United States: Wiley-Blackwell .

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

2008

Conference Publication

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

Kaisar, M., Armstrong, K., Prins, J., Marwick, T., Johnson, D., Hawley, C. and Isbel, N. (2008). The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology , Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell.

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

2008

Journal Article

The impact of automated eGFR reporting and education on nephrology service referrals

Noble, E, Johnson, DW, Gray, N, Hollett, P, Hawley, CM, Campbell, SB, Mudge, DW and Isbel, NM (2008). The impact of automated eGFR reporting and education on nephrology service referrals. Nephrology, Dialysis, Transplantation, 23 (12), 3845-3850. doi: 10.1093/ndt/gfn385

The impact of automated eGFR reporting and education on nephrology service referrals

2008

Conference Publication

Chronic kidney disease management: a multidisciplinary clinic model

Frazier, J., Blizzard, S., Douglas, B., Oliver, V., Johnson, D., Hawley, C., Campbell, S., Mudge, D. and Isbel, N. (2008). Chronic kidney disease management: a multidisciplinary clinic model. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Richmond, VIC, Australia: Wiley-Blackwell.

Chronic kidney disease management: a multidisciplinary clinic model

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Mollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology.

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

ELICITING PRIORITIES FOR RESEARCH FROM PATIENTS WITH CHRONIC KIDNEY DISEASE

Tong, A., Sainsbury, P., Harris, D., Walker, R., Hawley, C., Chadban, S., Hall, B., Carter, S. and Craig, J. C. (2007). ELICITING PRIORITIES FOR RESEARCH FROM PATIENTS WITH CHRONIC KIDNEY DISEASE. HOBOKEN: WILEY-BLACKWELL.

ELICITING PRIORITIES FOR RESEARCH FROM PATIENTS WITH CHRONIC KIDNEY DISEASE

2007

Conference Publication

COMPARING THE RELATIVE SURVIVAL ADVANTAGE BY STANDARDIZED MORTALITY RATIO OF AN AUSTRALIAN NHHD COHORT AND A MATCHED CONVENTIONAL HD COHORT FROM USRDS

Wilson, S., Van Epps, C., Hawley, C., Blagg, C. R. and Agar, J. W. M. (2007). COMPARING THE RELATIVE SURVIVAL ADVANTAGE BY STANDARDIZED MORTALITY RATIO OF AN AUSTRALIAN NHHD COHORT AND A MATCHED CONVENTIONAL HD COHORT FROM USRDS. HOBOKEN: WILEY-BLACKWELL.

COMPARING THE RELATIVE SURVIVAL ADVANTAGE BY STANDARDIZED MORTALITY RATIO OF AN AUSTRALIAN NHHD COHORT AND A MATCHED CONVENTIONAL HD COHORT FROM USRDS

2007

Conference Publication

PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION

Campbell, S., Hawley, C., Irish, A., Hutchison, B., Walker, R. and Ferrari, P. (2007). PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION. HOBOKEN: WILEY-BLACKWELL.

PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2027
    An adaptive, randomised controlled trial to treat polyomavirus infections (BKPyV) in kidney and kidney pancreas transplant recipients (BEAT-BK) trial (MRFF RCRDUN led by USyd)
    University of Sydney
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2020 - 2025
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC CTCS administered by USYD)
    University of Sydney
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au